Self-oxygenating nanoreactors enable effective low-dose X-ray photodynamic immunotherapy against refractory tumors.
Although low-dose radiotherapy (LDRT) exhibits high potential for radiotherapy, it meets a cascade of limitations for effectively eradicating refractory tumors due to low cell-killing effects, insufficient reactive oxygen species (ROS) production and acquired radio-resistance. Here, we engineered a new type of self-oxy...